Amanda is a current Harvard ALI Advisory Board member, a former Harvard Advanced Leadership Institute (ALI) Impact Leader 2024, and Research Fellow 2025. She was a Visiting Scientist at Harvard Chan School of Public Health from 2018-2022 after an earlier Harvard Fellowship in 2017.
She received a Member of the Order of Australia award (AM) or her services to public health and governance, and has over twenty-four years of company directorship experience including an ASX listed agribusiness.
Amanda chairs the National Blood Authority Australia, is Vice-President International Women’s Forum Australia, a member of the International Foundation for Valuing Impacts (IFVI) Technical and Research Committee, and an AICD Fellow and Faculty member. She is a former CEO of a leading health organisation and former director of Camp Quality, SA Motor Sport Board (V8 Supercars), Renewal SA, and National Heart Foundation SA.
She won a gold award at the Massachusetts Institute of Technology (MIT) AI Venture Studio 2024 and has since founded Impact Intelligence-AI Advisory, AI Foundry, and Impact Enterprises (2 AI climate-focused platforms). Her bespoke corporate advisory is focused on Artificial Intelligence (AI), Cyber resilience, Climate and Sustainability, Governance and Health. Amanda is an Associate Clinical Professor at Adelaide University and is a highly regarded keynote speaker.
Her Intensive Care related PhD included a novel decision-support system that successfully reduced adverse events by 80% in the ICU. In 2018 Amanda travelled to Sri Lanka with the Hands-On humanitarian group fitting 247 prosthetic hands to landmine victims.
Already a member?
Login to view this content